Henry Schein, Inc. (NASDAQ:HSIC) Receives $79.40 Average PT from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has earned an average recommendation of “Moderate Buy” from the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $79.40.

Several brokerages have recently issued reports on HSIC. Evercore ISI lifted their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Mizuho assumed coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

Institutional investors have recently made changes to their positions in the stock. Cromwell Holdings LLC raised its position in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Versant Capital Management Inc raised its holdings in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the last quarter. City State Bank acquired a new position in shares of Henry Schein in the 4th quarter worth approximately $55,000. Farther Finance Advisors LLC boosted its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after buying an additional 1,100 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

HSIC stock opened at $71.15 on Friday. The company’s 50-day moving average price is $72.18 and its two-hundred day moving average price is $70.57. The firm has a market cap of $8.87 billion, a P/E ratio of 29.28, a P/E/G ratio of 2.30 and a beta of 0.89. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.32 EPS. The firm’s revenue for the quarter was up .4% on a year-over-year basis. On average, analysts anticipate that Henry Schein will post 4.78 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.